| Literature DB >> 33551860 |
Sooah Jang1, JongKwan Choi2, Jooyoung Oh1,3, Jungyeon Yeom4, Narae Hong1, Narae Lee5, Joon Hee Kwon1, Jieun Hong6, Jae-Jin Kim1,3, Eunjoo Kim1,3.
Abstract
Virtual reality (VR) neuropsychological tests have emerged as a method to explore drug effects in real-life contexts in attention deficit hyperactivity disorder (ADHD) children. Functional near-infrared spectroscopy (fNIRS) is a useful tool to measure brain activity during VR tasks in ADHD children with motor restlessness. The present study aimed to explore the acute effects of methylphenidate (MPH) on behavioral performance and brain activity during a VR-based working memory task simulating real-life classroom settings in ADHD children. In total, 23 children with ADHD performed a VR n-back task before and 2 h after MPH administration concurrent with measurements of oxygenated hemoglobin signal changes with fNIRS. Altogether, 12 healthy control (HC) subjects participated in the same task but did not receive MPH treatment. Reaction time (RT) was shortened after MPH treatment in the 1-back condition, but changes in brain activation were not observed. In the 2-back condition, activation of the left dorsolateral prefrontal cortex (DLPFC) and bilateral medial prefrontal cortex (mPFC) was decreased alongside behavioral changes such as shorter RT, lower RT variability, and higher accuracy after MPH administration. Bilateral mPFC activation in the 2-back condition inversely correlated with task accuracy in the pre-MPH condition; this inverse correlation was not observed after MPH administration. In ADHD children, deactivation of the default mode network mediated by mPFC reduced during high working memory load, which was restored through MPH treatment. Our results suggest that the combination of VR classroom tasks and fNIRS examination makes it easy to assess drug effects on brain activity in ADHD children in settings simulating real-life.Entities:
Keywords: ADHD; Methylphenidate; fNIRS; mPFC; n-back; virtual reality; working memory
Year: 2021 PMID: 33551860 PMCID: PMC7859615 DOI: 10.3389/fpsyt.2020.564618
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157